A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_+_101349823 Show fit | 1.91 |
ENST00000519566.1
|
KB-1991G8.1 |
|
chr17_+_68047418 Show fit | 1.51 |
ENST00000586373.1
ENST00000588782.1 |
long intergenic non-protein coding RNA 1028 |
|
chr12_-_49463620 Show fit | 1.17 |
ENST00000550675.1
|
Ras homolog enriched in brain like 1 |
|
chr19_-_13900972 Show fit | 0.99 |
ENST00000397557.1
|
Uncharacterized protein |
|
chr12_-_111142729 Show fit | 0.98 |
ENST00000546713.1
|
hydrogen voltage-gated channel 1 |
|
chr3_+_167582561 Show fit | 0.90 |
ENST00000463642.1
ENST00000464514.1 |
RP11-298O21.6 RP11-298O21.7 |
|
chr11_+_115498761 Show fit | 0.87 |
ENST00000424313.2
|
AP000997.1 |
|
chr19_+_58193388 Show fit | 0.83 |
ENST00000596085.1
ENST00000594684.1 |
zinc finger protein 551 Uncharacterized protein |
|
chr16_-_21863541 Show fit | 0.83 |
ENST00000543654.1
|
nuclear pore complex interacting protein family, member B4 |
|
chr5_+_127039075 Show fit | 0.83 |
ENST00000514853.2
|
CTC-228N24.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.4 | GO:1903285 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.0 | 0.9 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.8 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 0.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.7 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 0.7 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.1 | 0.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 1.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.7 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.1 | 0.5 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.4 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.0 | 1.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 1.0 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.5 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.5 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.0 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.0 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |